Pfizer Inc

Sarasin & Partners LLP PFE

Report date

3/31/2026

Quarter

2026 Q1

Filed

4/13/2026

Shares

1,355,787

Value ($000)

38,071

Weight

0.5%

2013 Q4 - 2026 Q1 (29 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q1	4/13/2026	38,071	0.5%	1,355,787	3/31/2026
2025 Q4	1/8/2026	35,241	0.4%	1,415,294	12/31/2025
2025 Q3	10/10/2025	33,853	0.3%	1,419,406	9/30/2025
2025 Q2	7/9/2025	35,257	0.4%	1,454,498	6/30/2025
2025 Q1	4/15/2025	37,322	0.4%	1,472,852	3/31/2025
2024 Q4	1/16/2025	37,963	0.4%	1,430,940	12/31/2024
2024 Q3	10/9/2024	31,527	0.3%	1,089,401	9/30/2024
2024 Q2	7/19/2024	31,091	0.3%	1,111,179	6/30/2024
2024 Q1	4/12/2024	38,992	0.4%	1,405,135	3/31/2024
2023 Q4	1/10/2024	39,806	0.4%	1,382,631	12/31/2023
2023 Q3	10/5/2023	13,688	0.2%	412,658	9/30/2023
2023 Q2	7/11/2023	20,866	0.2%	568,857	6/30/2023
2023 Q1	4/27/2023	25,458	0.2%	456,898	3/31/2023
2022 Q4	1/30/2023	22,338	0.3%	435,940	12/31/2022
2022 Q3	10/18/2022	18,682	0.3%	426,928	9/30/2022
2022 Q2	7/13/2022	21,900	0.3%	417,697	6/30/2022
2022 Q1	4/11/2022	20,918	0.2%	404,062	3/31/2022
2021 Q4	1/19/2022	26,968	0.2%	456,701	12/31/2021
2021 Q3	10/22/2021	26,044	0.3%	605,529	9/30/2021
2021 Q2	7/13/2021	23,716	0.2%	605,621	6/30/2021
2021 Q1	4/29/2021	21,998	0.3%	607,170	3/31/2021
2020 Q4	1/19/2021	37,059	0.5%	1,006,769	12/31/2020
2020 Q3	11/9/2020	59,507	0.9%	1,621,455	9/30/2020
2020 Q2	7/17/2020	57,989	0.9%	1,773,378	6/30/2020
2020 Q1	4/30/2020	132,864	2.6%	4,070,601	3/31/2020
2019 Q4	2/12/2020	166,403	2.5%	4,247,135	12/31/2019
2014 Q2	7/14/2014	55,690	0.8%	1,876,345	6/30/2014
2014 Q1	4/9/2014	310,385	4.4%	9,663,301	3/31/2014
2013 Q4	2/13/2014	289,626	4.1%	9,455,640	12/31/2013